India to British Virgin Islands: Nivolumab Export Trade Route
India has recorded 1 verified shipments of Nivolumab exported to British Virgin Islands, representing a combined trade value of $5.7K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $5.7K USD. The leading Indian exporter is VEA IMPEX I PRIVATE LIMITED, which accounts for 100% of total export value with 1 shipments worth $5.7K USD. On the buying side, INVOICE RAISED TO BRITISH VIRGIN ISLANDS is the largest importer in British Virgin Islands with $5.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to British Virgin Islands Nivolumab corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $5.7K USD. The route is dominated by VEA IMPEX I PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's nivolumab manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $5.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with nivolumab's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 12.4%, placing it at rank #17 among India's top nivolumab export destinations globally.
On the import side, key buyers of Indian nivolumab in British Virgin Islands include INVOICE RAISED TO BRITISH VIRGIN ISLANDS. INVOICE RAISED TO BRITISH VIRGIN ISLANDS is the single largest importer with 1 shipments valued at $5.7K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ1
- Primary modeSea freight
- Top portBombay Air
Market Position
- Global rank#17
- Annual growth+12.4%
- Demand growth+12.8%
- Regulatory ease89/100
Top 10 Indian Nivolumab Exporters to British Virgin Islands
Showing top 10 of 1 Indian suppliers exporting Nivolumab to British Virgin Islands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VEA IMPEX I PRIVATE LIMITED Avg $5.7K per shipment | 1 | $5.7K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting nivolumab to British Virgin Islands, ranked by total trade value. The listed exporters are: VEA IMPEX I PRIVATE LIMITED. VEA IMPEX I PRIVATE LIMITED is the dominant supplier with 1 shipments worth $5.7K USD, giving it a 100% market share.
Top 10 Nivolumab Importers in British Virgin Islands
Showing top 10 of 1 known buyers in British Virgin Islands receiving Nivolumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian nivolumab in British Virgin Islands include INVOICE RAISED TO BRITISH VIRGIN ISLANDS. The largest importer is INVOICE RAISED TO BRITISH VIRGIN ISLANDS, accounting for $5.7K USD across 1 shipments — representing 100% of all nivolumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INVOICE RAISED TO BRITISH VIRGIN ISLANDS | 1 | $5.7K | 100.0% |
Top 10 Nivolumab Formulations Imported by British Virgin Islands
Showing top 10 of 1 product formulations shipped on the India to British Virgin Islands Nivolumab route, ranked by trade value
British Virgin Islands imports a wide range of nivolumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - OPDYTA 100MG 1VIAL NIVOLUMAB — accounts for $5.7K USD across 1 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL ARTICLE / ODS / PRODUCT / ITEM - OPDYTA 100MG 1VIAL NIVOLUMAB | 1 | $5.7K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Bombay Air handles the highest volume with 1 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's nivolumab exports to British Virgin Islands are driven primarily by a handful of large-scale manufacturers. VEA IMPEX I PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in British Virgin Islands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — VEA IMPEX I PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $5.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, INVOICE RAISED TO BRITISH VIRGIN ISLANDS is the largest importer with 1 shipments worth $5.7K USD — representing 100% of all nivolumab imports from India on this route.
Route Statistics
- Trade Volume
- $5.7K
- Avg. Shipment
- $5.7K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~22 days
- Annual Growth
- +12.4%
Other Nivolumab Routes
Unlock the Full India to British Virgin Islands Nivolumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 1 shipments on this route.
Frequently Asked Questions — India to British Virgin Islands Nivolumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Nivolumab to British Virgin Islands?
The leading Indian exporters of Nivolumab to British Virgin Islands are VEA IMPEX I PRIVATE LIMITED. VEA IMPEX I PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Nivolumab exports from India to British Virgin Islands?
India exports Nivolumab to British Virgin Islands worth approximately $5.7K USD across 1 recorded shipments. The average value per shipment is $5.7K USD.
Q Which ports does India use to ship Nivolumab to British Virgin Islands?
The most active port of origin is Bombay Air with 1 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to British Virgin Islands for Nivolumab?
The average transit time for Nivolumab shipments from India to British Virgin Islands is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to British Virgin Islands Nivolumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.4% with demand growth tracking at 12.8%. The route is ranked #17 among India's top Nivolumab export destinations globally.
Q How many suppliers are active on the India to British Virgin Islands Nivolumab route?
There are currently 1 active Indian suppliers exporting Nivolumab to British Virgin Islands. The market is moderately concentrated with VEA IMPEX I PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Nivolumab from India in British Virgin Islands?
The leading importers of Indian Nivolumab in British Virgin Islands include INVOICE RAISED TO BRITISH VIRGIN ISLANDS. INVOICE RAISED TO BRITISH VIRGIN ISLANDS is the largest buyer with 1 shipments worth $5.7K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to British Virgin Islands export trade corridor identified from Indian Customs (DGFT) records for Nivolumab.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in British Virgin Islands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 1 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists